Back
Design Therapeutics Stock Price Chart
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
39
DSGN
Design Therapeutics
Last Price:
3.72
Seasonality Move:
14.7%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight selling pressure.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.68 | Buy |
| 20-day SMA: | 3.73 | Sell |
| 50-day SMA: | 3.37 | Buy |
| 200-day SMA: | 3.07 | Buy |
| 8-day EMA: | 3.68 | Buy |
| 20-day EMA: | 3.66 | Buy |
| 50-day EMA: | 3.41 | Buy |
| 200-day EMA: | 3.79 | Sell |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 53.77 | Buy |
| Chaikin Money Flow: | -34795 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.63 - 3.85) | Sell |
| Bollinger Bands (100): | (2.36 - 3.5) | Buy |
Design Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 3.72 while DSGN 8-day simple moving average is 3.68, which is a Buy signal.
- The stock price of DSGN is 3.72 while Design Therapeutics 20-day SMA is 3.73, which makes it a Sell.
- Design Therapeutics 50-day simple moving average is 3.37 while DSGN share price is 3.72, making it a Buy technically.
- DSGN stock price is 3.72 and Design Therapeutics 200-day simple moving average is 3.07, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
39
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Sell
The current Design Therapeutics [DSGN] share price is $3.72. The Score for DSGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
210.16M
Price in USD:
3.72
Share Volume:
173.98K
Design Therapeutics 52-Week Range
52-Week High:
8.47
52-Week Low:
1.94
Sell
39
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?
The Design Therapeutics stock price is 3.72 USD today. -
Will DSGN stock go up or go down?
Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Design Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 3.72 while DSGN 8-day exponential moving average is 3.68, which is a Buy signal.
- The stock price of DSGN is 3.72 while Design Therapeutics 20-day EMA is 3.66, which makes it a Buy.
- Design Therapeutics 50-day exponential moving average is 3.41 while DSGN share price is 3.72, making it a Buy technically.
- DSGN stock price is 3.72 and Design Therapeutics 200-day simple moving average is 3.79, creating a Sell signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.14 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
- DSGN Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Design Therapeutics is a Buy
- Design Therapeutics Relative Strength Index (RSI) is 53.77, which suggest Design Therapeutics is overbought
- The Bollinger Bands (25) for Design Therapeutics is (3.63 - 3.85), which suggest Design Therapeutics is a Buy
- The Bollinger Bands (100) for Design Therapeutics is (2.36 - 3.5), which suggest Design Therapeutics is a Buy
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.